EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study
Sponsored by Medtronic Endovascular
About this trial
Last updated 6 years ago
Study ID
CP1007
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 11 years ago
What is this trial about?
The purpose of this study is to collect acute confirmatory data to evaluate technical
success and acute safety of the EverFlex™ self-expanding peripheral stent with Entrust™
delivery system.
What are the participation requirements?
Inclusion Criteria
- Has stenotic, restenotic (from PTA or adjunct therapy, not including stents or stent grafts),
- or occluded lesion(s) located in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) suitable for primary stenting.
Exclusion Criteria
- Has undergone previous implantation of stent(s) or stent graft(s) in the target vessel.